RenovoRx Announces New Clinical Data Supporting TAMP Therapy Platform to be Presented at SIO 2026 Annual Scientific Meeting

miércoles, 4 de febrero de 2026, 8:31 am ET1 min de lectura
RNXT--

RenovoRx will present clinical data at the SIO 2026 Annual Scientific Meeting, exploring the use of the TAMP therapy platform enabled by the RenovoCath catheter to optimize targeted delivery of chemotherapy in difficult-to-treat tumors. The study found that real-time intra-arterial pressure measurements can provide valuable insight into the mechanics of the approach and help clinicians refine drug-delivery variables.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios